Microbiome, Human Papillomavirus and Cervical Carcinogenesis

Area of Science:

• Microbiology
• Gynecology
• Immunology

Background:

• The vaginal microbiome comprises microorganisms crucial for health.
• Initially classified as healthy or bacterial vaginosis (BV), it's now detailed by community state types (CST).
• Lactobacillus species, particularly Lactobacillus crispatus (CST I), are associated with a healthy vaginal state.

Purpose of the Study:

• To explore the association between vaginal microbiome composition and cervical disease outcomes.
• To understand the role of specific CSTs, like CST I and CST IV, in human papillomavirus (HPV) infection and cervical neoplasia.
• To review emerging evidence on prebiotics and probiotics for cytological abnormality clearance.

Main Methods:

• Review of studies on vaginal microbiome composition using 16S sequencing.
• Analysis of associations between CSTs and cervical disease, including HPV infection and cervical intraepithelial neoplasia.
• Examination of mechanistic studies suggesting immunomodulatory roles.

Main Results:

• Lactobacillus spp. (CST I) is generally linked to healthy status.
• Bacterial vaginosis (BV) and CST IV are associated with increased risk of cervical intraepithelial neoplasia.
• Evidence suggests potential benefits of prebiotics and probiotics in clearing cytological abnormalities.

Conclusions:

• The vaginal microbiome's role in cervical health is significant, with specific CSTs correlating with disease risk.
• Further research, including longitudinal studies and mechanistic investigations, is needed.
• Novel therapeutic strategies targeting the vaginal microbiome show promise for improving cervical health outcomes.